KYMERA THERAPEUTICS INC's ticker is KYMR and the CUSIP is 501575104. A total of 128 filers reported holding KYMERA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.22 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $536,860 | -34.4% | 38,623 | +8.4% | 0.00% | 0.0% |
Q2 2023 | $818,973 | -16.0% | 35,623 | +8.2% | 0.00% | -33.3% |
Q1 2023 | $975,390 | +21.3% | 32,919 | +2.2% | 0.00% | 0.0% |
Q4 2022 | $803,787 | +7.7% | 32,203 | -6.0% | 0.00% | +50.0% |
Q3 2022 | $746,000 | +20.1% | 34,271 | +8.6% | 0.00% | 0.0% |
Q2 2022 | $621,000 | -68.1% | 31,557 | -31.4% | 0.00% | -50.0% |
Q1 2022 | $1,947,000 | -18.0% | 46,000 | +23.0% | 0.00% | -20.0% |
Q4 2021 | $2,375,000 | +8.1% | 37,400 | 0.0% | 0.01% | 0.0% |
Q3 2021 | $2,197,000 | +21.1% | 37,400 | 0.0% | 0.01% | +25.0% |
Q2 2021 | $1,814,000 | +243.6% | 37,400 | +175.0% | 0.00% | +300.0% |
Q1 2021 | $528,000 | – | 13,600 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Atlas Venture Life Science Advisors, LLC | 5,984,736 | $149,379,011 | 17.99% |
Aquilo Capital Management, LLC | 629,411 | $15,710,099 | 5.90% |
BVF INC/IL | 4,692,604 | $117,127,396 | 4.94% |
Artal Group S.A. | 2,000,000 | $49,920 | 2.79% |
Redmile Group, LLC | 2,673,837 | $66,738,972 | 2.73% |
Avoro Capital Advisors LLC | 3,850,000 | $96,096,000 | 1.44% |
Deer Management Co. LLC | 615,895 | $15,372,739 | 1.42% |
AtonRa Partners | 27,125 | $677,040 | 0.86% |
Rock Springs Capital Management LP | 1,227,779 | $30,645,364 | 0.74% |
EcoR1 Capital, LLC | 796,093 | $19,870,481 | 0.60% |